These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19738164)

  • 1. StatBite: Ovarian cancer: risk of recurrence by stage of diagnosis.
    J Natl Cancer Inst; 2009 Sep; 101(18):1234. PubMed ID: 19738164
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring ovarian cancer: CA125 trial stirs controversy.
    Chitale R
    J Natl Cancer Inst; 2009 Sep; 101(18):1233-5. PubMed ID: 19738165
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarian cancer, CA-125 addiction, and informed confusion: much ado about less.
    Tummala MK; McGuire WP
    J Clin Oncol; 2007 Aug; 25(24):3570-1. PubMed ID: 17704402
    [No Abstract]   [Full Text] [Related]  

  • 4. [Profiling of serum tumor markers in patients with epithelial ovarian carcinoma].
    Dong L; Li XP; Cui H; Wang JL; Wei LH; Zhao Y; Wang SJ; Wang Y; Sun XL; Liang XD; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):121-5. PubMed ID: 19570423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum levels of interleukin-10 in patients with ovarian carcinoma in response to chemotherapy].
    Zakrzewska I; Poznański J
    Przegl Lek; 2003; 60(1):18-20. PubMed ID: 12884640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of CA-125 in ovarian cancer].
    Mircea R; Frîncu DL; Dumitrache F
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1191-4. PubMed ID: 20191897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA-125 level preoperative assessment in early and advanced ovarian carcinoma.
    Raspollini MR
    Gynecol Oncol; 2007 Nov; 107(2):356-7; author reply 357-8. PubMed ID: 17716712
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jan; 116(1):57-60. PubMed ID: 19818996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress report on ovarian cancer screening. Scientists are making headway in detecting ovarian cancer at an earlier stage.
    Harv Womens Health Watch; 2010 Apr; 17(8):1-3. PubMed ID: 20506601
    [No Abstract]   [Full Text] [Related]  

  • 10. Personalizing ovarian cancer screening.
    Goozner M
    J Natl Cancer Inst; 2010 Aug; 102(15):1112-3. PubMed ID: 20668268
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian cancer: relevant therapy, not timing, is paramount.
    Morris RT; Monk BJ
    Lancet; 2010 Oct; 376(9747):1120-2. PubMed ID: 20888975
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovarian germ cell tumours: a 17-year study in a single unit.
    Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
    Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An atypical presentation of ovarian cancer.
    Moustafa M; Beynon WB
    J Obstet Gynaecol; 2002 Jul; 22(4):455-6. PubMed ID: 12521490
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic role of CA-125 nadir in stage IV epithelial ovarian cancer.
    Prat A; Parera M; Del Campo JM
    J Clin Oncol; 2008 Apr; 26(10):1771-2; author reply 1772. PubMed ID: 18375912
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ovarian carcinoma--diagnosis and treatment. Consensus conference of the National Institute of Health].
    Bornkessel B
    Med Monatsschr Pharm; 1995 Oct; 18(10):292-6. PubMed ID: 7476655
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
    Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
    Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of dynamic interpretation of CA 125 measurements to the understanding of an atypical clinical case].
    Riedinger JM; Mousseau M; Gauchez AS
    Ann Biol Clin (Paris); 2008; 66(3):333-40. PubMed ID: 18558573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psammoma bodies in cytological vaginal smears in metastatic ovarian carcinoma].
    Erz W; Stoll P; Schrage R
    Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):229-30. PubMed ID: 7789713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Serum CA-125 concentration in a patient with tuberculous peritonitis mimicking ovarian cancer.
    Kucok M
    J Reprod Med; 1998 Jul; 43(7):635-6. PubMed ID: 9693414
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre.
    Osman N; O'Leary N; Mulcahy E; Barrett N; Wallis F; Hickey K; Gupta R
    Ir Med J; 2008 Sep; 101(8):245-7. PubMed ID: 18990955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.